Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram

OBJECTIVE: To develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa). METHODS: Patients who underwent radical prostatectomy with pre-biopsy prostate MRI in three different centers were assessed retrospectively. Totally 141 and 60...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Guodong, Xing, Pengyi, Li, Zhihui, Ma, Xiaolu, Lu, Haidi, Shao, Chengwei, Lu, Yong, Lu, Jianping, Shen, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334707/
https://www.ncbi.nlm.nih.gov/pubmed/35912175
http://dx.doi.org/10.3389/fonc.2022.918830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334707/
https://www.ncbi.nlm.nih.gov/pubmed/35912175
http://dx.doi.org/10.3389/fonc.2022.918830

Ejemplares similares